¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Ç¥"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
cuticularization
Ç¥ÇÇÁõ½Ä, Ç¥ÇÇÇü¼º
epidermotrophism
Ç¥ÇÇÁöÇâ
desquamation
Ç¥ÇÇÅ»¶ô, »óÇÇÅ»¶ô, ºñ´Ã¹þÀ½
surface mold
Ç¥ÇÇÆ², Ç¥ÇÇÁÖÇü
Staphylococcus epidermidis
Ç¥ÇÇÆ÷µµ¾Ë±Õ, Ç¥ÇÇÆ÷µµ±¸±Õ
epidermal dysplasia
Ç¥ÇÇÇü¼ºÀÌ»ó
epidermodysplasia
Ç¥ÇÇÇü¼ºÀÌ»ó
phenomic
Ç¥Çö-
expressivity
Ç¥Çöµµ
expressive language
Ç¥Çö¾ð¾î
expressive aphasia
Ç¥Çö¾ð¾î»ó½ÇÁõ, Ç¥Çö½Ç¾îÁõ
expressive psychotherapy
Ç¥ÇöÁ¤½Å¿ä¹ý
phenomic lag
Ç¥ÇöÁöü
phenotype
Ç¥ÇöÇü
phenotypic expression
Ç¥ÇöÇü¹ßÇö
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
microbiologic marker
¹Ì»ý¹°Ç¥ÁöÀÚ
neuroepidermal
½Å°æÇ¥ÇÇ-
nasal smear
Ä๰Æì¹Ù¸¥Ç¥º»
nominal standard dose
¸í¸ñÇ¥Áؼ±·®
nomogram
°è»êµµÇ¥
nomography
³ë¸ð±×·¡ÇÇ, °è»êµµÇ¥ÇÐ
nonparametric test
ºñÁöÇ¥°ËÁ¤
nonsampling error
ºñÇ¥º»¿ÀÂ÷
normal pressure
Á¤»ó¾Ð, Ç¥ÁؾÐ
normogram
³ë¸ð±×·¥, °è»êµµÇ¥
null cell
¹«Ç¥Áö¼¼Æ÷
ocular hypertension indicator
°í¾È¾ÐÁöÇ¥
one stage sampling
ÀϴܰèÇ¥º»ÃßÃâ(¹ý)
open-label trial
°³¹æÇ¥Áö½ÃÇè
optotype
½Ã°¢Ç¥, ½ÃÇ¥
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
epidermis
Ç¥ÇÇ
epidermal
Ç¥ÇÇ-
epidermal cyst
Ç¥Çdz¶, Ç¥ÇÇÁÖ¸Ó´Ï
intraepidermal
Ç¥Çdz»-
acrosyringeal nevus
Ç¥Çdz»¶¡»ù°ü¸ð¹Ý
intraepidermal nevus
Ç¥Çdz»¸ð¹Ý
intra-epidermal epithelioma
Ç¥Çdz»»óÇÇÁ¾
epidermal nevus
Ç¥ÇǸð¹Ý
epidermal nevus syndrome
Ç¥ÇǸð¹ÝÁõÈıº
epitheloid cyst
Ç¥ÇǸð¾ç³¶Á¾
subepidermal
Ç¥ÇǹØ-, Ç¥ÇÇÇÏ
subepidermal nodular fibrosis
Ç¥ÇǹذáÀý¼¶À¯Áõ
subepidermal bulla
Ç¥Çǹع°Áý, Ç¥ÇÇÇϹ°Áý
subcuticular suture
Ç¥ÇǹغÀÇÕ
subepidermal calcified nodule
Ç¥Çǹؼ®È¸°áÀý
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
histogram
È÷½ºÅä±×·¥, ¸·´ëÇ¥
hanging drop specimen
ÇöÀûÇ¥º»
haphazard sample
ÆíÀÇÇ¥º»
health indicator
º¸°ÇÁöÇ¥, °Ç°ÁöÇ¥
hemizona assay index
¹ÝÅõ¸í¶ìÃøÁ¤ÁöÇ¥
hereditary leptocytosis
À¯ÀüÇ¥ÀûÀûÇ÷±¸Áõ
hereditary stigma
À¯Àü¡ǥ
household sample survey
°¡±¸Ç¥º»Á¶»ç
hysterical stigma
È÷½ºÅ׸®Â¡Ç¥
sclerosing epithelial hamartoma
°æÈÇ¥Çǰú¿ÀÁ¾
index
ÁöÇ¥, Áö¼ö
indication
Áö½Ã, ¡Á¶, Ç¥½Ã, Á¶Ä¡
indicator
ÁöÇ¥, Áö½Ã°è
iodinated
¿ä¿ÀµåÇ¥½Ä-
imaging parameter
¿µ»óÁöÇ¥, ¿µ»óº¯¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
2
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
recreational-expressional therapy
À¯ÈñÇ¥Çö¿ä¹ý(ë´ýôøúúÞèþÛö)
rectangular coordinates
Á÷°¢ÁÂÇ¥(òÁÊÇ ñ¦øö).
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
superficial gastritis
Ç¥À缺 À§¿°(¡êÖæú)
superficial gastritis
Ç¥À缺 À§¿°(¡êÖæú).
atrophoscleroderma superficialis
Ç¥À缺 À§Ãà °æÇÇÁõ(øúî¤àõ ê×õê Ìãù«ñø)
endometriosis cutaneus
Ç¥À缺 Àڱ󻸷Áõ.
superficial fungus infection
Ç¥À缺 Áø±Õ°¨¿°(øúî¤àõòØÐ¶Êïæø).
superficial fungus infection
Ç¥À缺 Áø±Õ°¨¿°(øúî¤àõòØÐ¶Êïæø).
superficial fungus infections
Ç¥À缺 Áø±Õ°¨¿°(øúî¤àõòØÐ¶Êïæø).
mycosis, superficial
Ç¥À缺 Áø±ÕÁõ, üǥÁø±ÕÁõ
superficial abrasion
Ç¥À缺 Âû°ú
superficial abrasion
Ç¥À缺 Âû°ú(øúî¤àõóÍΦ)
encephalitis haemorrhagica superior<³ª>
Ç¥À缺 ÃâÇ÷¼º ³ú¿°.
superficial staphylococcal infection
Ç¥À缺 Æ÷µµ±¸±Õ°¨¿°(øúî¤àõøãԬϹж Êïæø).
nevus lipomatosus cutaneus superficialis
Ç¥À缺 ÇǺÎÁö¹æÁ¾¸ð¹Ý
nevus lipomatosus cutaneus superficialis
Ç¥À缺 ÇǺÎÁö¹æÁ¾¾ç¸ð¹Ý(øúî¤àõ ù«Ý±ò·Û¸ðþåË)
fungal disease,superficial
Ç¥À缺(øúî¤àõ)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
dermoepidermal junction
ÁøÇÇÇ¥ÇÇ¿¬°á, ÁøÇ¥ÇÇÁ¢ÇÕºÎ(òØøúù«ïÈùêÝ»).
dermoepidermal junction
ÁøÇÇÇ¥ÇÇ¿¬°á(òØù«øúù«Ö§Ì¿)
dermoepidermal junction
ÁøÇÇÇ¥ÇÇ¿¬°á, ÁøÇ¥ÇÇÁ¢ÇÕºÎ(òØøúù«ïÈùêÝ»)
desquamation
¹Ú¸®, ³«¼³, Ç¥ÇÇÅ»¶ô
developmental expressive language disorder
¹ß´Þ¼º Ç¥Çö¾ð¾îÀå¾Ö(Û¡Ó¹àõ øúúÞåëåÞî¡äô)(º´)
developmental expressive writing disorder
¹ß´Þ¼º Ç¥Çö¾²±âÀå¾Ö(Û¡Ó¹àõ øúúÞ~î¡äô)(º´)
developmental milestone
¹ß´ÞÀÌÁ¤Ç¥(Û¡Ó¹ìÅïïøú)
diagram
µµÇ¥(ËÀ̰), µµÇü(ËÀÌ´).
diazo
µð¾ÆÁ¶¡ì-N =-N-¡íÀÇ Á¸À縦 Ç¥½ÃÇÏ´Â Á¢µÎ¾î.
display
Ç¥½Ã (øúãÆ)
display
µð½ºÇ÷¹ÀÌ, Ç¥½Ã
display console
µð½ºÇ÷¹ÀÌ ÄܼÖ, Ç¥½Ã ÄܼÖ
display mode
Ç¥½Ã ¹æ½Ä
display pattern
Ç¥½Ã ¾ç»ó
display system
Ç¥½Ã ÀåÄ¡
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
9
ÄÚµå
¿µ¹®
ÇѱÛ
T31.8
Burns involving 80-89£¥ of body surface
½Åüǥ¸éÀÇ 80-89£¥¸¦ Æ÷ÇÔÇÑ È»ó
T31.9
Burns involving 90£¥ or more of body surface
½Åüǥ¸éÀÇ 90£¥ÀÌ»óÀ» Æ÷ÇÔÇÑ È»ó
T32
Corrosions classified according to extent of body surface involved
Æ÷ÇÔµÈ ½Åüǥ¸éÀÇ Á¤µµ¿¡ µû¶ó ºÐ·ùµÈ ºÎ½Ä
T32.0
Corrosions involving less than 10£¥ of body surface
½Åüǥ¸éÀÇ 10£¥ ¹Ì¸¸À» Æ÷ÇÔÇÑ ºÎ½Ä
T32.1
Corrosions involving 10-19£¥ of body surface
½Åüǥ¸éÀÇ 10-19£¥¸¦ Æ÷ÇÔÇÑ ºÎ½Ä
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
¼³¸í
mucocutaneous
Á¡¸· Ç¥ÇÇ, Á¡¸· »óÇÇ, Á¡¸· ÇǺÎ, Á¡¸· ÇǺÎÀÇ, Á¡¾× ÇǺÎÀÇ
1. Á¡¸·°ú ÇǺο¡ ¿µÇâÀ» Áִ ȤÀº ¿©±â¿¡ °ü°èµÈ. 2. Á¡¸· ¹× ÇǺÎÀÇ ¶Ç´Â ±×°ÍÀ» ħ½ÀÇÏ´Â.
mucoepidermoid
Á¡¾× Ç¥ÇǾç
mucoepidermoid tumor
Á¡¸· À¯Ç¥ÇÇ ¾Ï, Á¡¾× Ç¥ÇǾç Á¾¾ç
muscle of facial expression
¾È¸é Ç¥Á¤ ±Ù
´«, ÄÚ, ÀÔ ÁÖÀ§¿¡ ÀÖ´Â ±ÙÀ°À» ¾È¸é Ç¥Á¤ ±ÙÀ̶ó Çϸç, Á¾·ù¿¡´Â ±¤°æ±Ù
neuronal representation
´º¿ì·± Ç¥Çö
normal value
Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
oral screen
±¸³» Â÷ÆóÆÇ, ±¸° Ç¥ÁظÁ
ÇϾǰñ ¿îµ¿¿¡ °ü¿©ÇÏ´Â ±ÙÀ°À» ¿îµ¿½ÃŰ´Â ÀåÄ¡. ¼Õ°¡¶ô »¡±â, ÀÔ¼ú ±ú¹°±â, Çô ³»¹Ð±â, ±¸È£Èí µî¿¡ Àû¿ëÇÑ´Ù.
paramimia
Âø¿À Ç¥Á¤
»ý°¢À» Ç¥ÇöÇÏ´Â µ¥ ÀÖ¾î¼ ¸öÁþÀ» À߸ø ¾²´Â °ÍÀ¸·Î, ´ëÈ ½Ã ±×¸©µÈ ¶Ç´Â Àû´çÄ¡ ¾ÊÀº ¸öÁþÀ» ¾²´Â °Í.
paratype
ºÎ¸ð½Ä Ç¥º»
¿ø·¡ÀÇ ºÐ·ù ±âÀç°¡ ±× ±âÁØ¿¡ ÀǰÅÇÑ °ÍÀ̶ó°í Ưº°È÷ ±â¼úÇÑ Á¤±âÁØÁÖ ÀÌ¿ÜÀÇ ¼¼±ÕÁÖ.
periapical radiograph
±¸³» Ç¥ÁØ ÃÔ¿µ, Ä¡±Ù´Ü ¹æ»ç¼± »çÁø
periderm
¿ÜÇ¥ÇÇ
1. ÅÂ¾Æ Ç¥ÇÇ, ÀÌÃþ¼ºÀÇ ÅÂ¾Æ Ç¥ÇÇ Áß Å« ¼¼Æ÷·Î ÀÌ·ç¾îÁø ¿ÜÃþÀ¸·Î, »ç¶÷¿¡°Ô¼´Â ±× ¹Ø¿¡ ¹ßÀ°ÇÏ´Â ¸ð¹ß ¶§¹®¿¡ ¾û¼ºÇÏ°Ô µÇ¾îÀÖ°í ÀϹÝÀûÀ¸·Î Ãâ»ê Àü¿¡ ¼èÅðÇÑ´Ù. 2. ¼ÒÇÇ, »óÁ·ÇÇ¿Í ÇÏÁ·ÇǷμ »ýÈÄ¿¡µµ Á¸¼ÓÇÏ´Â ÅÂ¾Æ Ç¥ÇÇÀÇ À¯ÀÏÇÑ ºÎºÐ.
phase display
À§»ó Ç¥½Ã
phenogenesis
Ç¥ÇöÇü ¹ß»ý
phenomic lag
Ç¥Çö Áö¿¬
phenotype
Ç¥ÇöÇü
¾î¶² À¯ÀüÀÚ ¶Ç´Â À¯ÀüÀÚ±ºÀÇ Áö¹è¿¡ ÀÇÇØ ¹ß°ßµÇ´Â ÇüÁúÀÇ ÇüÀÌ ÀÖ´Ù. Ç¥ÇöÇüÀº À¯ÀüÀÚ¿Í È¯°æÀÇ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ °áÁ¤µÇ´Â °æ¿ì°¡ ¸¹´Ù. µû¶ó¼ ÀÏÁ¤ÀÇ À¯ÀüÀÚÇü¿¡ ´ëÀÀÇϴ ǥÇöÇü¿¡´Â Â÷À̰¡ ÀÖ´Ù.
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
card rate
Ç¥ÁظÅü¿ä±Ý(½Å¹®»ç.¹æ¼Û±¹ µîÀÌ °øÇ¥ÇÑ ±¤°í Ç¥ÁØ ¿ä±ÝÇ¥)
standard time
Ç¥ÁؽÃ
standardize
Ç¥ÁØ¿¡ ¸ÂÃß´Ù;±Ô°ÝÈ ÇÏ´Ù;Ç¥Áß¿¡ ÀÇÇÏ¿© ½ÃÇèÇÏ´Ù
Standard English
Ç¥ÁØ¿µ¾î
stock
Ç¥ÁØÀÇ, º¸ÅëÀÇ
normal
Ç¥ÁØÀÇ;±Ô°Ý´ë·ÎÀÇ;Á¤±ÔÀÇ;ÀüÇüÀûÀÎ;Á¤»óÀÇ;»óÅÂÀÇ;º¸ÅëÀÇ;Æò±ÕÀÇ;(»ç¶÷ÀÌ)Á¤»óÀûÀ¸·Î ¹ß´ÞÇϰí ÀÖ´Â;¼öÁ÷ÀÇ;(¿ë¾×ÀÌ)±ÔÁ¤ÀÇ;(½ÇÇ赿¹°ÀÌ)Á¤»óÀÇ;(¸é¿ªµî)ÀÚ¿¬ÀÇ
substandard
Ç¥ÁØÀÌÇÏÀÇ
standard play
Ç¥ÁØÆÇ;SPÆÇ
standardization
Ç¥ÁØÈ
standardization
Ç¥ÁØÈ;±Ô°ÝÈ;ÅëÀÏ;ȹÀÏ
normalization
Ç¥ÁØÈ;Á¤»óÈ
normalize
Ç¥ÁØÈÇÏ´Ù(±¹±³µîÀ»)Á¤»óÈÇÏ´Ù;(Ç¥±â¸¦)ÀÏÁ¤ÇÑ ÀýÂ÷¹ýÀ¸·Î ÅëÀÏÇÑ;Ç¥ÁØÈ(Á¤»óÈ)µÇ´Ù
first cover
Ç¥Áö
tagging
Ç¥Áö ¹æ·ù
tagged atom
Ç¥Áö(°¡ºÙÀº) ¿øÀÚ(¹æ»ç¼º ¿øÀÚÇÙÀ» °¡Áø ¿øÀÚ,ƯÀ¯ÇÑ ¹æ»ç´É¿¡ ÀÇÇÏ¿© ½Äº°ÇÒ ¼ö ÀÖÀ½)
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
state's attorney
ÁÖ´ëÇ¥ÀÇ º¯È£»ç
statement
Áø¼ú,¼º¸í,°è»êÇ¥
stock
Ç¥ÁØÀÇ, º¸ÅëÀÇ
subhead
ÀÛÀº Ç¥Á¦
subtitle
ÀÛÀº Ç¥Á¦
suffrage
ÅõÇ¥
superficial
¸éÀûÀÇ; Ç¥¸éÀÇ; ÇÇ»óÀûÀÎ
superficiality
Ç¥¸éÀûÀÓ
superficially
Ç¥¸éÀûÀ¸·Î
surface
Ç¥¸é,Ç¥¸éÀÇ
suspension
¸Å´Þ±â; ºÎÇ¥; ¹Ì°á; Á¤ÇÐ; ÁßÁö
table
Å×À̺í,½ÄŹ,Ç¥,Æò¿ø,´ëÁö
tabulate
Ç¥·Î ¸¸µé´Ù
tabulation
Ç¥·Î ¸¸µé±â
tag
²¿¸®Ç¥
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½